IL17A and cancer: Additionally, detection of the IL‐17A+ cell percentage in clinical samples also supported the hypothesis that IL‐17A plays a pro‐metastatic role in HCC, consistent with the effects on diverse cancer types (McAllister and Kolls, 2015; Wu et al., 2016; Zhu et al., 2008).